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Abstract: The presence of the HGF/Met system in the testicular myoid cells was first 
discovered by our group. However, the physiological role of this pathway remains poorly 
understood. We previously reported that HGF increases uPA secretion and TGF-β 
activation in cultured tubular fragments and that HGF is maximally expressed at  
Stages VII–VIII of the seminiferous epithelium cycle, when myoid cell contraction occurs. 
It is well known that the HGF/Met pathway is involved in cytoskeletal remodeling; 
moreover, the interaction of uPA with its receptor, uPAR, as well as the activation of  
TGF-β have been reported to be related to the actin cytoskeleton contractility of smooth 
muscle cells. Herein, we report that HGF induces actin cytoskeleton remodeling in vitro in 
isolated myoid cells and myoid cell contraction in cultured seminiferous tubules. To better 
understand these phenomena, we evaluated: (1) the regulation of the uPA machinery in 
isolated myoid cells after HGF administration; and (2) the effect of uPA or Met inhibition 
on HGF-treated tubular fragments. Because uPA activates latent TGF-β, the secretion of 
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this factor was also evaluated. We found that both uPA and TGF-β activation increase after 
HGF administration. In testicular tubular fragments, HGF-induced TGF-β activation and 
myoid cell contraction are abrogated by uPA or Met inhibitor administration. 
Keywords: myoid cells; HGF/c-Met; uPA; actin cytoskeleton; TGF-β 
 
1. Introduction 
Hepatocyte growth factor (HGF) is a pleiotropic cytokine originally purified as a potent mitogen for 
hepatocytes [1,2] and subsequently identified as a “scatter factor” [3,4] for its ability to disperse sheets 
of contiguous epithelial cells [3]. HGF is secreted as an inactive, single-chain precursor that is cleaved 
to acquire its active form. HGF activation can be provided by the HGF activator protein (HGFA),  
a serine protease able to cleave immature HGF precursor to form the mature bioactive protein, or by 
active metalloproteinases (MMP2 and MMP9), as well as by plasminogen activator (PA) [5]. 
The action of HGF is mediated by a specific receptor, Met. This receptor is normally expressed by 
epithelial cells, whereas HGF production has been mainly found to be restricted to cells of mesenchymal 
origin. These findings suggest a relevant role for HGF in mesenchymal-epithelial interactions [6].  
We previously reported that HGF and Met are expressed in the postnatal rat testis and influence many 
functional activities of testicular somatic and germ cells (for a review, see [7]). In myoid cells,  
HGF is expressed at both prenatal and postnatal ages, whereas Met is expressed by myoid cells only 
during postnatal rat testis development, indicating that this lineage becomes sensitive to HGF only 
postnatally [8–10]. In Sertoli cells, Met is absent up to 20–25 days postpartum, but low levels of 
expression begin at puberty [10]. Interestingly, in adult rats, HGF is maximally expressed at Stages 
VII–VIII of the seminiferous epithelium cycle, when germ cells traverse the blood–testis barrier (BTB) 
and spermiation occurs, whereas its level falls in the subsequent Stages IX–XII and XIII–I [11]. 
Myoid cells represent an interesting model of smooth muscle cells that contain desmin-type 
intermediate filaments [12] and α-smooth muscle isoactin as a specific differentiation marker [13]. 
Myoid cells surrounding the seminiferous tubule are responsible for tubular contractility, which is important 
for the progression of spermatozoa toward the rete testis. The regulation of myoid cell contractility 
occurs under endocrine-paracrine control. A variety of substances have been shown to affect myoid 
cell activity, including oxytocin [14], vasopressin [15], prostaglandins [16] and endothelin [17,18]. 
We previously reported that HGF is involved in the control of peritubular myoid cell spreading  
in vitro [8]. Interestingly, in the seminiferous tubule compartment, we have shown that HGF is mainly 
produced by myoid cells and adult Sertoli cells [8,19]. Moreover, we demonstrated that HGF increases 
the amount of the secreted TGF-β active fraction [20,21] in cultured seminiferous tubules. Intriguingly, 
it has been reported that TGF-β induces the contractility of smooth muscle cells [22] and that HGF 
might have an indirect effect on TGF-β by affecting molecules, such as plasminogen activator (PA), 
that are able to activate the latent form of the protein [23]. 
Plasminogen activators (PAs) are serine proteases that cleave the proenzyme, plasminogen, which is 
present in plasma and extracellular fluids, into the active protease plasmin. Two forms of PA, 
urokinase type (uPA) and tissue type (tPA), have been characterized in mammals; these proteins have 
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different catalytic and antigenic properties and are encoded by two distinct genes [24]. These proteases 
are produced by a large number of cell and tissue types and are involved in physiological and 
pathological processes that require localized and controlled proteolysis [25] and/or local activation of 
growth factors [26]. Beyond the regulation of proteolysis, uPA is implicated in processes, such as cell 
migration, adhesion and proliferation and vascular remodeling [27]. uPA-induced signal transduction 
can be mediated via a specific receptor (uPAR), and a parallel between the remodeling of the actin 
cytoskeleton of smooth muscle cells and the interaction of uPA and its receptor, uPAR, has been 
reported in the literature [28,29]. 
To increase our knowledge on the effects exerted by HGF in the control of myoid cell functions,  
in the present paper, we investigated the capability of this growth factor to remodel the actin 
cytoskeleton of myoid cells and consequently modulate peritubular contractility. 
To this aim, we analyzed the morphological effect of HGF treatment on isolated myoid cells and  
on seminiferous tubules isolated from the testes of animals at different postnatal ages. Moreover,  
we evaluated the gene expression of tPA, uPA, the uPA receptor, uPAR, and the uPA inhibitor, PAI-1, 
in control conditions and after HGF administration in isolated myoid cells. In the same culture 
conditions, the secretion of uPA, tPA and PAI-1 was also quantified. Finally, we observed the effect of 
uPA inhibition on the cytoskeleton of HGF-treated myoid cells in seminiferous tubule organ cultures. 
The effect of Met inhibition on myoid cell contraction and on TGF-β activation in cultured tubular 
fragments has been also evaluated. 
2. Results 
2.1. Effect of HGF on Cell Shape and the Actin Cytoskeleton of Cultured Myoid Cells 
It has been previously demonstrated that the morphology of myoid cells cultured in the presence of 
HGF changes from a round shape to an elongated, enlarged shape [7]. To understand whether  
this change in cell morphology was associated with actin fiber polymerization and cytoskeletal 
rearrangement, myoid cells were stained with rhodamine-labeled phalloidin. In the control cells,  
the characteristic meshwork of actin filaments was observed (Figure 1A). The addition of 150 U/mL 
(45 ng/mL) HGF resulted in a rearrangement of the cytoskeleton, with the actin filaments assembled to 
form bundles of stress fibers (Figure 1B). 
 
Figure 1. F-actin distribution pattern in cultured myoid cells purified from prepubertal rat 
testes. The figure shows the F-actin cytoskeletal pattern of purified myoid cells cultured for 
24 h in medium alone (control) (A) or in the presence of 150 U/mL (45 ng/mL) HGF (B). 
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2.2. Effect of HGF on Myoid Cells Organized in Isolated Seminiferous Tubules 
Seminiferous tubules were isolated from rats of different ages (17/18, 35 and 60 days) and  
cultured in the presence or absence of 150 U/mL (45 ng/mL) HGF. At the end of incubation, the actin 
cytoskeleton was stained with rhodamine-labeled phalloidin, and the seminiferous tubules were 
observed with a confocal microscope. In all of the different ages examined, the myoid cells were 
arranged in a continuous layer of epithelioid polygonal cells with the actin cytoskeleton showing  
a characteristic orthogonal meshwork (Figures 2A, 3A and 4A). The exposure of tubules to 150 U/mL 
(45 ng/mL) HGF resulted in a change in the cytoskeleton organization, with the centrally-located 
fibers forming evident rings. In prepubertal animals (Figure 2B), this pattern of response was observed 
in almost the whole peritubulum, whereas in pubertal rats, an evident spotted pattern was observed, 
although with a stronger response (Figure 3B(b)). To understand the mechanism behind this differential 
response, we performed the same experiments utilizing adult rats, where it is possible to distinguish 
the different stages of the seminiferous epithelium cycle and where myoid cell contraction starts to be 
physiologically important. In HGF-treated tubules, we observed the spotted pattern of cytoskeletal 
organization, which was similar to the tubules isolated from pubertal animals, exclusively at  
Stages VI-VIII. A representative confocal image of this stage is shown in Figure 4. In the other stages, 
no differences in the morphology of peritubular myoid cells were observed after HGF treatment.  
To test the specificity of the reported HGF-dependent myoid cell contraction, we performed the same 
experiments on adult testis tubular fragments using the Met-specific inhibitor, PF-04217903.  
As expected, the Met inhibitor administration abrogated the HGF-dependent myoid cell contraction  
(Figure 4C,D). 
 
Figure 2. Confocal analysis of F-actin cytoskeletal modifications in cultured prepubertal rat 
seminiferous tubules. The figure shows the F-actin cytoskeletal pattern of prepubertal rat 
seminiferous tubules cultured for 24 h in medium alone (control) (A,a) or in the presence 
of 150 U/mL (45 ng/mL) HGF (B,b), 15 μM aprotinin (C,c) or HGF + aprotinin (D,d). 
Lower magnification (A–D) and higher magnification (a–d) of the images are shown. 
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Figure 3. Confocal analysis of F-actin cytoskeletal modifications in cultured pubertal rat 
seminiferous tubules. The figure shows the F-actin cytoskeletal pattern of pubertal  
rat seminiferous tubules cultured for 24 h in medium alone (control) (A,a) or in the presence of 
HGF (B,b). Lower magnification (A,B) and higher magnification (a,b) of the images are shown. 
 
Figure 4. Confocal analysis of F-actin cytoskeletal modifications in cultured adult rat 
seminiferous tubules isolated at Stages VI–VIII. The figure shows the F-actin cytoskeletal 
pattern of adult rat seminiferous tubules (Stages VI–VIII) cultured for 24 h in medium 
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alone (control) (A,a) or in the presence of HGF (B,b), Met-inhibitor (C,c),  
HGF + Met-inhibitor (D,d), amiloride (E,e), HGF + amiloride (F,f), aprotinin (G,g) and 
HGF + aprotinin (H,h). Lower magnification (A–H) and higher magnification (a–h) of the 
images are shown. 
2.3. Presence of MET 
The expression of MET mRNA in the myoid cells during postnatal testis development has been 
previously demonstrated by northern blot analysis [8,10]. However, to test whether the differential 
response to HGF at the different ages and at different epithelium seminiferous stages was due to  
a non-homogeneous distribution of the HGF receptor, Met, tubules isolated from the testes of 
prepubertal (Figure 5, Panel I) or adult (Figure 5, Panel II) rats were analyzed by immunofluorescence 
with anti-Met antibody. Confocal microscopy analysis showed that the myoid cell layer of the 
seminiferous tubules was always positive for Met, and the staining was independent of the age and the 
stage of the cycle (Figure 5). However, the intensity of Met positivity among neighboring myoid cells 
was variable, although it was not possible to relate this parameter to the age or the stage of the cycle. 
 
Figure 5. Cont. 
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Figure 5. Confocal analysis of Met immunolocalization in prepubertal and adult rat 
seminiferous tubules. (Panel I): (A) Met distribution pattern in the peritubular compartment 
is shown. (a) Higher magnification of the square drawn in (A); asterisks indicate myoid 
cells. (B) Met distribution pattern imaged at the internal level of the same seminiferous 
tubule of (A). (b) Higher magnification of the square drawn in (B); arrows indicate myoid 
cells; (Panel II): (A) Transmission bright field images of seminiferous tubules at Stages 
VI–VIII (B) and I–V (C). (B,C) Relative Met distribution pattern at the internal level of 
the tubules shown in the squares in (A). (D) Met distribution pattern imaged at the 
peritubular myoid level of a seminiferous tubule at Stages VI–VIII. Asterisks indicate 
myoid cells. (E) Met distribution pattern imaged at the internal level of a seminiferous 
tubule at Stage X. Arrows indicate myoid cells. 
2.4. Effect of Inhibition of PA Activity on Actin Cytoskeleton Remodeling 
Urokinase PA and the interaction with its receptor, uPAR, have been implicated in actin 
cytoskeleton organization and adhesion capacity in vascular smooth muscle cells [29]. To test whether 
the observed effects of HGF on myoid cell shape and actin cytoskeleton rearrangement were mediated 
by PA activity, tubules isolated from prepubertal and adult rats were cultured for 24 h in the presence 
of 15 μM aprotinin alone or in combination with 150 U/mL (45 ng/mL) HGF. As shown in Figure 2C 
and Figure 4G, aprotinin alone did not affect the actin cytoskeleton, but the combination of aprotinin 
and HGF almost completely abolished the effect of HGF (Figures 2D and 4H). To test the specificity  
of the results obtained, we performed the same experiments on tubules isolated from adult rats with 
another PA inhibitor (amiloride), obtaining overlapping results (Figure 4E,F). 
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2.5. Effects of HGF on PA Activity in Cultured Rat Myoid Cells 
To evaluate the effect of HGF on myoid cell PA secretion, the cells were incubated for 24 h  
in MEM supplemented with 0.1% BSA in the presence of different concentrations of HGF  
(25–300 U/mL; 7.5–90 ng/mL). The culture medium was then analyzed for PA activity by zymography. 
The results of a representative experiment are shown in Figure 6 (Panel I). A band with an apparent 
molecular mass of approximately 45 kDa, corresponding to rat uPA, was the predominant enzyme 
present in the conditioned medium (Figure 6, Panel I). After HGF stimulation, uPA secretion was 
increased in a dose-dependent manner.  
 
Figure 6. Cont. 
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Figure 6. HGF mediated a uPA secretion increase in purified myoid cells and in cultured 
seminiferous tubules. (Panel I) Dose-response curve of uPA secreted by purified myoid cells 
cultured for 24 h in the presence of increasing doses of HGF (25–300 U/mL; 7.5–90 ng/mL). 
Aliquots of conditioned medium were analyzed by SDS-PAGE followed by zymography. 
The bands were analyzed by densitometry. Values represent the mean ± SEM of three 
separate experiments and are expressed as fold induction relative to control, which was set 
equal to one. * p < 0.05; ** p < 0.01 and *** p < 0.001; (Panel II) Time course of PA 
production by purified myoid cells cultured in medium alone (left) or in the presence of 
150 U/mL (45 ng/mL) HGF (right). The uPA bands were analyzed by densitometry. 
Values represent the mean ± SEM of three separate experiments and are expressed as 
arbitrary units. * p < 0.05; ** p < 0.01; (Panel III) uPA secreted by tubular fragments 
cultured for 24 h in control condition, with Met inhibitor alone or in combination with 
HGF. Values are expressed as arbitrary units. a vs. b p < 0.05. The same letters indicate 
values that are not statistically significant. 
PA activity was quantified by densitometric scanning of zymographies, and the values are 
expressed as fold induction with respect to the values of the controls, which were set equal to one  
(Figure 6, Panel I). For the subsequent experiments, a dose of 150 U/mL (45 ng/mL) HGF was used. 
The effect of HGF on PA secretion was also evaluated at different culture times. Myoid cells were 
cultured in medium alone (control) or with 150 U/mL (45 ng/mL) HGF for the times indicated in  
Panel II of Figure 6. In HGF-treated cultures, there was a significant increase in uPA production, 
which reached a plateau at 48 h, whereas in the control conditions, the increase was less evident.  
At these longer times of culture, a band with an apparent molecular mass of approximately 70 kDa 
corresponding to rat tPA became evident in the control conditions. However, after hormonal 
stimulation, we observed a decrease in tPA production. In all zymographies of HGF-treated cells,  
a band with a higher molecular weight appeared, suggesting the presence of a PA–PAI complex. 
Urokinase PA activity was quantified by densitometric scanning of zymographies, and the values are 
expressed as arbitrary units (Figure 6, Panel II). 
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2.6. Effects of Met Inhibition on PA Activity in Cultured Adult Seminiferous Tubule Fragments 
We previously demonstrated that HGF administration to tubules at Stages VII–VIII is able to  
increase the uPA level [11]. Herein, we report that the selective inhibition of Met by PF-04217903 is 
able to abrogate this effect, indicating the specific and direct role of HGF on uPA modulation  
(Figure 6, Panel III). 
2.7. Hormonal Regulation of tPA, uPA, PAI-1 and uPAR mRNA Levels 
To determine whether the effects of HGF on PA activity were associated with changes in mRNA 
levels, total RNA was extracted from myoid cells cultured for 24 h in the presence or absence  
of 150 U/mL (45 ng/mL) HGF and analyzed by multiplex PCR (Figure 7). 
A densitometric analysis of the bands revealed that after hormonal stimulation, there was an  
8.3-fold increase in uPA mRNA levels, whereas tPA mRNA decreased by 30% compared with the 
values found in basal conditions (Figure 7, Panel I). The observed levels of mRNA mirrored the 
enzymatic activity of both tPA and uPA in the culture medium (Figure 6, Panel II). 
Urokinase PA activity is regulated by the binding of uPA to its receptor, uPAR, and by the 
inhibitor, PAI-1. Therefore, we also analyzed the levels of uPAR and PAI-1 mRNA. As shown in  
Panel II of Figure 7, HGF induced a significant increase in uPAR mRNA (50%), but did not significantly 
change the levels of PAI-1 mRNA. 
2.8. Transforming Growth Factor-β (TGF-β) Production 
Myoid cells were cultured for 24 h in control medium or in medium supplemented with 150 U/mL 
(45 ng/mL) HGF, and the secretion of total and active TGF-β was evaluated using a bioassay based on 
mink lung epithelial cells (MLECs), as described in the Methods Section. The results obtained 
indicated that HGF significantly increased the secretion of both total and active TGF-β (Figure 8, 
Panel I). The same assay was performed on tubular fragments isolated at Stages VI–VIII and cultured 
in the control condition, in the presence of uPA or Met inhibitor alone or in combination with HGF. 
Actually, we already reported that active TGF-β increases after HGF administration to tubular 
fragments [11]. Herein, we confirm this result, adding new information. In fact the co-administration 
of HGF with Met or uPA inhibitors abolished the HGF-dependent TGF-β activation. Furthermore,  
Met inhibitor alone was able to reduce the mean level of active TGF-β, even though the differences are 
not statistically significant. This result suggests that the HGF-mediated TGF-β activation is 
physiological (Figure 8, Panel II). 
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Figure 7. uPA, tPA, uPAR and PAI-1 gene expression level after HGF administration.  
(Panel I): The effect of HGF stimulation on uPA (A) and tPA (B) gene expression, as 
detected by multiplex RT-PCR. Myoid cells were cultured for 24 h in medium alone C or 
in the presence of 150 U/mL (45 ng/mL) HGF. Total RNA was subjected to RT-PCR, and 
aliquots of the PCR products were electrophoresed on a 1.5% agarose gel (top). The values 
of the uPA and tPA PCR products were normalized to their corresponding GAPDH values 
and are expressed as fold induction with respect to C, which was arbitrarily set to one. 
Values represent the mean ± SEM of three separate experiments. * p < 0.05; ** p < 0.001. 
(Panel II): The effect of HGF stimulation on uPAR (A) and PAI-1 (B) gene expression as 
detected by multiplex RT-PCR. Myoid cells were cultured for 24 h in medium alone C or 
in the presence of 150 U/mL (45 ng/mL) HGF. Total RNA was subjected to RT-PCR, and 
aliquots of the PCR products were electrophoresed on a 1.5% agarose gel (top). The values 
of uPAR and PAI-1 PCR products were normalized to their corresponding GAPDH values 
and are expressed as fold induction with respect to C, which was arbitrarily set to one. 
Values represent the mean ± SEM of three separate experiments. * p < 0.05. 
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Figure 8. HGF dependent TGF-β secretion and activation in purified myoid cells and in 
cultured seminiferous tubules. (I): TGF-β secreted by purified myoid cells. The amounts of 
active (A) and total (B) TGF-β in the control C and HGF-treated samples are shown.  
The values represent the mean ± SEM of four different experiments and are expressed as 
fold induction with respect to the control, which was arbitrarily set to one. * p < 0.05;  
** p < 0.01; (Panel II): Active TGF-β secreted by cultured tubular fragments at  
Stages VI–VIII of the seminiferous epithelium cycle. The amounts of active TGF-β 
secreted in the control condition and after HGF administration are shown. The effect on 
TGF-β activation due to amiloride or Met inhibitor administered alone or in combination 
with HGF is also reported. The values represent the mean ± SEM and are expressed as fold 
induction with respect to the control, which was arbitrarily set to one. a vs. b p < 0.01;  
the same letters indicate values that are not statistically significant. 
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3. Discussion 
Rat spermatozoa are shed from the seminiferous tubules at the end of Stage VIII of the seminiferous 
cycle and are transported toward the rete testis to the epididymis, where they acquire motility.  
This movement has been postulated to occur by the secretion and flow of fluid in the seminiferous 
tubules and to be triggered by the contractile activity of the tubules themselves. Myoid cells, which 
surround the seminiferous tubules, are responsible for tubular contractility, and a variety of substances 
have been shown to affect their activity, including oxytocin [30], vasopressin [15], prostaglandins [16] 
and endothelin [17,18]. We previously demonstrated that myoid cells cultured in the presence of HGF 
modify their morphology, changing from a round, compact shape to an elongated, enlarged shape [8]. 
In the present work, we investigated the capability of HGF to induce actin cytoskeleton remodeling 
and to modulate myoid cell contraction. This effect was studied both in cells isolated from prepubertal 
testes and in peritubular myoid cells of seminiferous tubules from rats of different ages. A change in 
myoid cell cytoskeletal organization was detected in all samples treated with HGF. In particular, 
isolated myoid cells showed an HGF-dependent actin cytoskeletal rearrangement highlighted by the 
formation of actin filament stress-fiber bundles, whereas myoid cells of HGF-treated tubular fragments 
showed centrally-located actin fibers forming evident rings, which resemble the actin organization of 
contracted myoid cells [17]. 
We noted that in tubular fragments from prepubertal rats, HGF clearly induced a myoid cell F-actin 
reorganization that was fairly homogeneous in the whole peritubular compartment. In contrast,  
in pubertal and adult tubules, we observed that the arrangement of actin cytoskeleton sharpened in the 
spotted areas of the peritubular compartment, suggesting a local regulation of responsiveness to HGF 
in pubertal and adult myoid cells. 
To better understand this phenomenon, tubules from adult testes were isolated at the different stages 
of the seminiferous epithelium cycle. Intriguingly, changes in the actin cytoskeleton were mainly 
observed in tubules cultured at Stages VI–VIII, and it is worth mentioning that this effect did not occur 
when Met inhibitor was administered. We hypothesized that a differential response to HGF may reflect 
differences in Met expression along the tubules. Therefore, we analyzed Met expression at the 
peritubular myoid level in the different stages of the seminiferous epithelium cycle. We found that the 
pattern of Met distribution in the myoid cells of prepubertal and adult tubular fragments appeared 
similar in all of the samples analyzed and was independent of the age and the stage of the seminiferous 
epithelium cycle, although Met fluorescence intensity was not homogeneous in the neighboring myoid 
cells. On the basis of these results, it is conceivable to hypothesize that the differential myoid cell 
responsiveness to HGF might be due to the physiological availability of the factor and/or other 
cytokines produced that affect the contractility of the myoid cell lineage. In this regard, we have 
demonstrated that HGF is maximally expressed at Stages VII–VIII of the seminiferous epithelium  
cycle [11], which is the same stage in which myoid cells appeared to respond to HGF administration. 
Moreover, the reported HGF mediated-myoid cell contraction might also be mediated by the  
HGF-dependent upregulation of other factors known to trigger smooth muscle cell contraction. 
Therefore, the control of differential tubular contractility might be obtained by the regulation of the 
secretion of the factors involved in this process. Because we previously reported that the treatment of 
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isolated tubules with HGF induced an increased secretion of uPA together with an increase in TGF-β 
activation [11], we decided to study the uPA dependence of HGF-mediated myoid cell contraction. 
Like other proteins, both PAs have been shown to be secreted in a cyclic fashion during the cycle  
of the seminiferous epithelium [31,32], and this control appears to occur at the mRNA level.  
High levels of uPA mRNA were found at Stages VII–VIII, whereas the highest levels of tPA mRNA 
were identified at Stages IX–I [33,34]. 
The production of uPA at Stages VII–VIII has been suggested to be involved in the extensive tissue 
remodeling that takes place during the release of the preleptotene spermatocytes from the basement 
membrane [35], spermiation [36] and the detachment of residual bodies from the mature spermatids [37]. 
uPA and the interaction with its receptor, uPAR, have been positively implicated in reorganization 
of the actin cytoskeleton and the adhesion of vascular smooth muscle cells [29]. Moreover, uPA can 
activate inactive plasminogen, forming the broad-spectrum serine protease plasmin, which, in turn, 
facilitates the conversion of latent TGF-β to the active form; this is based on the fact that plasmin  
has been reported to catalyze this conversion [23]. In addition, it has been demonstrated that  
receptor-bound uPA is required for the plasmin-dependent cellular conversion of latent TGF-β to 
active TGF-β [38]. TGF-β has been demonstrated to stimulate the assembly of F-actin microfilaments 
to form bundles of stress fibers on peritubular cells in culture and also induces an increased 
contractility of peritubular cells embedded in collagen gels [39]. 
Consistent with these literature data, herein, we show that HGF is able to mediate an increase of 
uPA and its receptor, uPAR, in purified myoid cells. Moreover, in the same cultural conditions,  
we also observed an increased activation of TGF-β after HGF stimulation. Therefore, the reported 
secretion of uPA by myoid cells, as well as the presence of its receptor, uPAR, might be relevant to the 
process of TGF-β activation. Interestingly we previously demonstrated that HGF was able to increase 
the uPA level also when administered to adult tubular fragments at the Stages VII–VIII of the 
seminiferous epithelium cycle [11]. Indeed, when PA activity was inhibited by aprotinin or amiloride, 
we abolished the contractile effect of HGF, indicating that this effect was mediated by this enzyme. 
Moreover the use of amiloride, as well as the Met selective inhibitor abolished the HGF-dependent 
TGF-β activation. In light of this result, we indicate that the observed HGF-mediated uPA activity 
increase influences the active TGF-β secretion and might thus be responsible, at least in part, for the 
increased contractility of HGF-treated myoid cells. Further investigation is needed to clarify the 
physiological pathway crosstalk among HGF and the other cytokines known to regulate myoid  
cell contraction. 
In conclusion, in this study, we provide evidence that: (1) Met is expressed by myoid cells of 
prepubertal, pubertal and adult rat seminiferous tubules; (2) HGF activates testicular myoid cell 
cytoskeleton remodeling and contraction; (3) in the adult, myoid cell contraction, due to HGF 
administration, is sharp only in tubules cultured at Stages VI–VIII of the seminiferous epithelium 
cycle, which are the stages when myoid cell contraction physiologically occurs, and Met inhibitor 
administration abolishes this phenomenon; (4) also aprotinin and amiloride, which are uPA inhibitors, 
abrogate HGF-induced myoid cell contraction; (5) HGF is able to increase the expression level of uPA 
and uPAR in purified testicular myoid cells; (6) Met inhibitor administration on tubular fragments 
abolish the HGF-dependent uPA increase; (7) HGF is able to increase the secretion of active TGF-β, 
which, interestingly, is one of the factors known to be involved in peritubular cell contraction and can 
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be activated by uPA; and (8) Met or uPA inhibitor administration abolishes HGF-dependent  
TGF-β activation. 
On the basis of these results, we propose to include HGF in the number of factors able to locally 
modulate, directly and/or indirectly via TGF-β activation, testicular myoid cell contraction. 
4. Materials and Methods 
4.1. Animals 
Wistar rats were housed under controlled temperature (25 °C) and light (12 h light/day) conditions 
with ad libitum access to food and water at the Sapienza University of Rome, Rome, Italy. All animal 
studies were conducted in accordance with the Italian Department of Health Guide for Care and Use of 
Laboratory Animals. The protocol (ID 149321853903) was approved by the Committee on the Ethics 
of Animal Experiments of the “Sapienza” University of Rome 19 November 2013 (legal provision  
art. 116/92). Rats were sacrificed by CO2 asphyxia before testis removal. Typically, nine or ten  
17–18-day-old rats and three or four 28–60-day-old rats were used for each experiment. 
4.2. Cell Preparation and Culture 
Purified myoid cells were prepared according to the method of Palombi et al. [40]. In brief, small 
explants of decapsulated testes isolated from 17–18-day-old rats were digested for 30 min at 32 °C  
by 0.25% trypsin in PBS to detach the interstitium. The seminiferous tubules were sedimented  
by gravity, and the supernatant was removed and centrifuged to sediment the interstitial cells.  
The seminiferous tubules were treated with collagenase A (1 mg/mL) for 30 min at 32 °C to detach  
the total peritubular cells and then again sedimented by gravity. The supernatant was removed, and  
the tubules were washed with PBS and sedimented again. The supernatant was removed, pooled with 
the first and centrifuged for 2 min at 40× g. The pellet was further digested in 0.1% trypsin in PBS 
supplemented with 2% EDTA to obtain a single cell suspension, which was applied to a discontinuous 
Percoll gradient and centrifuged for 20 min at 800× g at room temperature. The fraction corresponding 
to the myoid cells (density 1.075 g/mL) was collected, and the cells were washed twice with MEM. 
The purity of the cells used for the experiments was assayed by the presence of alkaline phosphatase 
activity [40] and was never lower than 94%. For assessment of the effects of HGF in vitro, cells were 
cultured in plastic dishes for 24 h at 32 °C in a humidified 5% CO2/95% air atmosphere in the presence 
of HGF (150 U/mL= 45 ng/mL). At the end of the culture, the conditioned media were collected and 
used for the PA and TGF-β assays. Myoid cells were either fixed in 4% paraformaldehyde (PFA) and 
used for F-actin detection or solubilized in lysis buffer for RNA extraction (see below). 
4.3. Isolation of Seminiferous Tubule Fragments 
Tubules were prepared as we previously described, with minor modifications to better preserve  
the peritubular myoid layer [11,20]. The albuginea of the testes of 17/18- and 35-day-old rats were 
dissected, and the seminiferous tubules were mechanically isolated and digested with 0.25% and  
0.2% trypsin, respectively, in Hank’s buffer without Ca2+ and Mg2+ at 32 °C in a shaking water bath  
(90 cycles/min). After 3–5 min, the enzyme was diluted with Hank’s buffer, and the seminiferous 
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tubules were collected by sedimentation (5 min). The albuginea of the testes of 60-day-old rats were 
removed, and the seminiferous tubules were mechanically dissected without enzymatic digestion. 
Tubules at Stages VII–VIII of the seminiferous epithelial cycle were isolated according to the method 
of Parvinen and Vanha-Perttula [41]. Tubules of all ages considered were washed three times with 
Hank’s buffer and three times with MEM to eliminate the interstitial tissue. To determine myoid cell 
layer integrity, some of the tubules were assayed by the presence of alkaline phosphatase activity [40]. 
The isolated tubules were cultured for 24 h at 32 °C in a humidified atmosphere of 5% CO2 in air. 
These samples were cultured in control medium and in medium supplemented, when indicated, with 
150 U/mL (45 ng/mL) HGF, 15 µM aprotinin, 100 µM amiloride and 30 and 60 nM PF-04217903 
(Sigma–Aldrich Corp., St. Louis, MO, USA), which is a Met-selective inhibitor. These compounds, 
when indicated, were added in combination. The concentration of amiloride was used according to  
Zhu et al. [42]. The working concentration of the Met inhibitor was determined by a dose response 
scatter assay carried out on MDCK cells [8]. In this assay, we used PF-04217903 at concentration  
of 5, 10, 20, 30, 60 nM and 1 µM. We found that 30 nM is the lowest concentration of PF-04217903 
able to inhibit HGF-induced MDCK scatter activity. After culture, the media were collected and used 
for TGF-β bioassay and PA zymography (see below), whereas the tubules were washed twice  
in PBS and fixed in 4% PFA for 2 h at 4 °C for immunofluorescence experiments and confocal 
microscopy analyses. 
4.4. Met Immunofluorescence 
For Met detection, fixed tubules were rinsed three times in PBS. To determine myoid cell layer 
integrity, some of the tubules were assayed by the presence of alkaline phosphatase activity [40].  
Non-specific antibody binding was blocked by rinsing samples for 1 h in PBS with 3% BSA and  
0.1% Triton X-100. The seminiferous tubules were then incubated overnight with anti-Met antibody  
(sc 162G m-Met SP260, 1:1 dilution, Santa Cruz Biotechnology, Heidelberg, Germany). Samples were 
then washed three times in PBS with 1% BSA and 0.1% Triton X-100. The secondary antibody  
(FITC-conjugated donkey anti-goat IgG; 1:200 dilution) was incubated for 1 h at RT. Negative controls 
were treated with secondary antibody only. After secondary antibody incubation, tubules were washed 
three times in PBS, mounted in buffered glycerol (pH 9) and visualized using the confocal microscope. 
4.5. F-Actin Detection 
For F-actin visualization, fixed purified myoid cells and seminiferous tubules were rinsed  
three times in PBS for a total of 15 min. Samples were then permeabilized with 0.1% Triton X-100 in 
PBS for 2 h, rinsed three times in PBS and treated with rhodamine-phalloidin (R415) (Life Technologies, 
Molecular Probes, Eugene, OR, USA) at 25 μL/mL for 20 min. After incubation with phalloidin, 
samples were washed three times in PBS and mounted in buffered glycerol (pH 9). Seminiferous 
tubules were visualized using the confocal microscope, whereas myoid cells were photographed with a 
Zeiss Axioscope microscope. 
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4.6. Confocal Microscopy 
For actin and Met detection, a Leica confocal microscope (Laser Scanning TCS SP2, Leica, 
Wetzlar, Germany) equipped with Ar/ArKr and He/Ne lasers was utilized. The images were acquired 
using the Leica confocal software. The laser line was at 488 nm for FITC excitation (Met) and 543 nm 
for rhodamine excitation (actin). The images were scanned under a 20× objective. Isolated seminiferous 
tubules were analyzed using optical spatial series with a step size of 1 μm. Images were taken at the 
peritubular myoid cell layer and at the central part of the tubules. 
4.7. RNA Extraction and RT 
Total RNA from cultured myoid cells was isolated using a silica gel-based membrane spin column 
(RNeasy Kit, Qiagen S.p.A., Hilden, Germany). The purity and integrity of the RNA was assessed 
spectroscopically and by gel electrophoresis. Total RNA (1 µg) was reverse transcribed in a final 
volume of 20 µL using the M-MLV Reverse Transcriptase kit (Invitrogen, Waltham, MA, USA), 
according to the manufacturer’s instructions. 
4.8. Multiplex PCR 
To determine the presence of the uPA, tPA, uPAR and PAI-1 transcripts, a duplex PCR was performed. 
The reactions were performed using a Multiplex PCR Kit (Qiagen, Hilden, Germany) according to the 
manufacturer’s instructions, with the housekeeping gene, GAPDH, used as an internal control. 
The primer sequences chosen are shown in Table 1. Each primer pair was previously tested alone 
for specific amplification. For each sample, 10 μL of PCR product was then subjected to 
electrophoresis on a 2% (w/v) agarose gel and stained with ethidium bromide. The densitometric 
evaluation of the bands was performed with AIDA software (Advanced Image Data Analyzer 2.11 
raytest GmbH, Straubenhartd, Germany). The relative mRNA levels were normalized against  
the expression of the housekeeping gene. DNA contamination controls were performed using  
gene-specific primers on RNA without reverse transcriptase treatment. 
Table 1. Sequence of oligonucleotides used as RT-PCR primers. 
Gene Primers 
Product 
Length 
Reaction 
Conditions 
Gene Bank  
Accession Number 
GAPDH 
Fw 5'-TTCAACGGCACAGTCAAGGCT-3' 
552 bp  NM_017008.4 
Rv 5'-ATTGGGGGTAGGAACACGGAA-3' 
uPA 
Fw 5'-CCCTGCCTGGCCTGGAATTC-3' 
664 bp 
Ann: 59 °C, 30" 
NM_013085.3 
Rv 5'-CCAAACGGAGCATCACCAAACC-3' Elong: 72 °C, 30" 
uPAR 
Fw 5'-GAAGACCAACAGGACCATGAGC-3' 
462 bp 
Ann: 55 °C, 30" 
NM_134352.1 
Rv 5'-CATCCAAAGGTGCTGTTCCC-3' Elong: 72 °C, 30" 
tPA 
Fw 5'-GGGGGTACGTGTCAGCAGGCC-3' 
621 bp 
Ann: 62 °C, 30" 
NM_013151.2 
Rv 5'-CGCAGGTGGAGCATGGGGAC-3' Elong: 72 °C, 30" 
PAI-1 
Fw 5'-CTGGTGCTGGTGAACGCCCTC-3' 
338 bp 
Ann: 59 °C, 30" 
NM_012620.1 
Rv 5'-CAGGATGAGGAGGCGGGGC-3' Elong: 72 °C, 30" 
Fw, forward primer; Rv, reverse primer. 
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4.9. Bioassay for TGF-β 
Active TGF-β was assayed according to the method of Abe et al. [43], which utilizes a mink lung 
epithelial cell (MLEC) line stably transfected with the luciferase gene. Conditioned media were 
prepared from myoid cells and tubular fragments cultured for 24 h as described above. Conditioned 
medium (100 μL) was then added to subconfluent MLECs. After 16 h of culture at 37 °C in 5% CO2, 
MLECs were washed twice with phosphate-buffered saline (PBS), lysed in 60 μL of lysis buffer 
(Promega, Madison, WI, USA) and stored at −80 °C until use. Cell extracts were assayed for luciferase 
activity using a kit obtained from Promega and a Netzschalter 090003 luminometer (GSG Nuclear, 
Milan, Italy). To measure total TGF-β, latent TGF-β was activated by treating the conditioned medium 
at 80 °C for 6 min, and the media were assayed for TGF-β activity. Parallel MLECs were incubated 
with known increasing concentrations of TGF-β (Sigma T1654, ranging from 0.0625 to 4.0 ng/mL) to 
obtain a standard curve. 
4.10. Gel Electrophoresis and Zymography 
For zymography of the plasminogen activator (PA), 10 μL of conditioned medium were separated 
by 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) under non-reducing 
conditions according to the procedure of Laemmli [44]. Molecular weights were calculated from the 
position of prestained molecular weight markers (Bio–Rad, Milan, Italy, 161-0373) subjected to 
electrophoresis in parallel lanes. PA was then visualized by placing the Triton X-100 washed gel on a 
casein-agar-plasminogen underlay, as previously described [25,45]. All of the bands were plasminogen 
dependent. The densitometric analysis of the band was performed to obtain semiquantitative 
estimation of protease activities 
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